Literature DB >> 18502471

Ageing within the hematopoietic stem cell compartment.

Daniel Pearce1, Dominique Bonnet.   

Abstract

As we humans are far too aware, all mammals have a finite lifespan. Apart from basic longevity, age is also a major risk factor for most cancers and diseases. Since adult stem cells are responsible for maintaining tissue homeostasis throughout an organism's lifetime, an attractive theory is that ageing-related phenotypes might be, at least in part, due to an alteration in the number and/or function of tissue stem cells. Here, we have focused on hematopoietic stem cells as they are one of the best-characterized adult stem cell populations, and have been extensively studied for the consequences of ageing in vivo and in vitro.

Entities:  

Mesh:

Year:  2008        PMID: 18502471     DOI: 10.1016/j.mad.2008.04.005

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  3 in total

1.  Developing a quantitative measurement system for assessing heterotopic ossification and monitoring the bioelectric metrics from electrically induced osseointegration in the residual limb of service members.

Authors:  Brad M Isaacson; Jeroen G Stinstra; Rob S MacLeod; Paul F Pasquina; Roy D Bloebaum
Journal:  Ann Biomed Eng       Date:  2010-05-11       Impact factor: 3.934

2.  Human blood and marrow side population stem cell and Stro-1 positive bone marrow stromal cell numbers decline with age, with an increase in quality of surviving stem cells: correlation with cytokines.

Authors:  S K Brusnahan; T R McGuire; J D Jackson; J T Lane; K L Garvin; B J O'Kane; A M Berger; S R Tuljapurkar; M A Kessinger; J G Sharp
Journal:  Mech Ageing Dev       Date:  2010-10-28       Impact factor: 5.432

3.  Changes in the frequencies of human hematopoietic stem and progenitor cells with age and site.

Authors:  Tracy L Farrell; Timothy R McGuire; Laura D Bilek; Susan K Brusnahan; John D Jackson; Judy T Lane; Kevin L Garvin; Barbara J O'Kane; Ann M Berger; Sonal R Tuljapurkar; M Anne Kessinger; John Graham Sharp
Journal:  Exp Hematol       Date:  2013-11-15       Impact factor: 3.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.